Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Maiese · SciRah

Researcher profile · Semantic Scholar

E. Maiese

Share profile

E. Maiese — researcher profile on SciRah

h-index: 14
Works: 78
Citations: 826

Most-cited papers

The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis
I. Al-Dakkak, Seema M. Patel, E. McCann, A. Gadkari +2 more
2012AIDS Care143 citations Open access
Semantic Scholar
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma
R. Fonseca, S. Usmani, M. Mehra, M. Slavcev +8 more
2020BMC Cancer117 citations Open access
Semantic Scholar
Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
L. Saager, E. Maiese, L. Bash, T. Meyer +8 more
2019Journal of clinical anesthesia109 citations
Semantic Scholar
Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors
F. Ducharme, F. Noya, Felicia C. Allen-Ramey, E. Maiese +2 more
2012Current Medical Research and Opinion54 citations
Semantic Scholar
Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma
B. Durie, Shaji K. Kumar, S. Usmani, B. Nonyane +5 more
2020American journal of hematology/oncology41 citations Open access
Semantic Scholar
Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Jonathan D. Campbell, Felicia C. Allen-Ramey, S. Sajjan, E. Maiese +1 more
2011American Journal of Managed Care38 citations
Semantic Scholar
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
E. Maiese, C. Ainsworth, J. Le Moine, Outi Ahdesmäki +2 more
2018Clinical Therapeutics32 citations Open access
Semantic Scholar
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
S. Saidha, J. Bell, Sydney Harold, J. Belisario +4 more
2023Neurological Sciences31 citations Open access
Semantic Scholar
Patient Satisfaction, Preventive Services, and Emergency Room Use among African-Americans with Type 2 Diabetes
T. L. Gary, E. Maiese, Marian L. Batts-Turner, Nae-Yuh Wang +1 more
2005Disease management : DM29 citations
Semantic Scholar
Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons
E. Maiese, Phaedra T. Johnson, T. Bancroft, Alyssa Goolsby Hunter +1 more
2016Current Medical Research and Opinion21 citations
Semantic Scholar
Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients
Todd A. Lee, Chun‐Lan Chang, J. Stephenson, S. Sajjan +3 more
2010Current Medical Research and Opinion21 citations
Semantic Scholar
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators
J. Sabatino, K. Mittl, W. Rowles, C. Zamecnik +13 more
2022Multiple Sclerosis and Related Disorders20 citations Open access
Semantic Scholar
Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States.
E. Maiese, K. Evans, B. Chu, D. Irwin
2018American health & drug benefits18 citations
Semantic Scholar
Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality
K. Muessig, A. Panter, M. S. Mouw, K. Amola +4 more
2015AIDS Patients Care and STDs17 citations Open access
Semantic Scholar
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment.
L. Batchelder, S. Philpott, V. Divino, N. Boytsov +5 more
2022Future Oncology13 citations Open access
Semantic Scholar
A U.S. Cost Analysis of Triplet Regimens for Patients with Previously Treated Multiple Myeloma.
S. Hollmann, D. Moldaver, N. Goyert, D. Grima +1 more
2019Journal of Managed Care & Specialty Pharmacy12 citations Open access
Semantic Scholar
Impact of comorbidities on HIV medication persistence: a retrospective database study using US claims data
E. Maiese, M. Malmenäs, M. Atkinson
2012Journal of the International AIDS Society12 citations Open access
Semantic Scholar
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study.
R. Rifkin, D. Singer, K. Aguilar, B. Baidoo +1 more
2019Clinical Therapeutics11 citations Open access
Semantic Scholar
Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States
M. DeKoven, C. Makin, Samantha Slaff, M. Marcus +1 more
2016Journal of the International Association of Providers of AIDS Care11 citations Open access
Semantic Scholar
Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States
Ji-Nan Liu, B. Emond, E. Maiese, M. Lafeuille +5 more
2022Current Medical Research and Opinion10 citations Open access
Semantic Scholar
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
P. Varughese, Robert Smith, M. Xue, N. Dorrow +3 more
2022Expert Review of Hematology7 citations
Semantic Scholar
Factors associated with the selection of initial antiretroviral therapy from 2009 to 2012
M. Saag, Andrew O. Westfall, Stephen R. Cole, W. C. Mathews +5 more
2017Journal of Acquired Immune Deficiency Syndromes7 citations Open access
Semantic Scholar
Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic.
P. Coyle, M. Gorritz, R. Wade, Zifan Zhou +4 more
2023Multiple Sclerosis and Related Disorders5 citations Open access
Semantic Scholar
Real-world cost of care and site of care in patients with multiple sclerosis initiating infused disease-modifying therapies
E. Alvarez, K. Nair, Hiangkiat Tan, Kapil Rathi +4 more
2023Journal of Medical Economics5 citations Open access
Semantic Scholar
Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study
L. Gordan, Melody Chang, M. Lafeuille, H. Romdhani +3 more
2021Drugs - Real World Outcomes5 citations Open access
Semantic Scholar
A Retrospective Comparison of Acute Rhinosinusitis Outcomes in Patients Prescribed Antibiotics, Mometasone Furoate Nasal Spray, or Both
C. de Moor, G. Reardon, J. Mclaughlin, E. Maiese +1 more
2012American Journal of Rhinology & Allergy5 citations
Semantic Scholar
An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure.
A. Nikolaou, C. Hogea, Y. Samyshkin, E. Maiese +5 more
2022Value in Health4 citations Open access
Semantic Scholar
Patient Preferences for Multiple Myeloma (MM) Treatment: Interim Analysis of a Discrete Choice Experiment
C. Mckay, E. Maiese, J. Chiarappa, M. J. Cambron-Mellott +3 more
2018Blood4 citations
Semantic Scholar
Real-World Utilization and Safety of Daratumumab Rapid Infusion Administered in a Community Setting: A Retrospective Observational Study
Lucio Gordon, Melody Chang, M. Lafeuille, H. Romdhani +4 more
2019Blood3 citations
Semantic Scholar
Trends in survival and costs among U.S. patients with multiple myeloma.
E. Maiese, K. Evans, B. Chu, D. Irwin
20173 citations
Semantic Scholar
Incidence of corneal adverse events in patients with multiple myeloma and their clinical and economic impact: A real-world retrospective cohort study
Feng Wang, L. Sansbury, S. Ferrante, E. Maiese +5 more
2022Journal of Medical Economics2 citations Open access
Semantic Scholar
Physician decision-making on use of treatments for relapsed/refractory multiple myeloma (RRMM) in later lines: What drives preferences?
L. Batchelder, S. Philpott, V. Divino, N. Boytsov +5 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States
Anshul Shah, J. Tosh, A. Ambavane, A. Nikolaou +5 more
2021ClinicoEconomics and Outcomes Research2 citations Open access
Semantic Scholar
Effectiveness of Daratumumab in Combination with Lenalidomide and Dexamethasone (DRd) Vs. Common Standard-of-Care Regimens in Patients with Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM)
B. Durie, Shaji K. Kumar, S. Usmani, B. Nonyane +5 more
2019Blood2 citations
Semantic Scholar
PIN45 The Impact of HIV Treatment-Related Adverse Events on Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
E. Maiese, I. Al-Dakkak, E. McCann, S. Patel +2 more
20122 citations Open access
Semantic Scholar
NALIRIFOX Compared With FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma: An Overall Survival External Control Arm Study
D. King, M. S. Duh, Rose Chang, L. Yu +3 more
2026Journal of Clinical Pathways1 citations
Semantic Scholar
Treatment patterns among patients with advanced/recurrent endometrial cancer in the United States.
E. Maiese, B. Emond, Ji-Nan Liu, M. Lafeuille +5 more
2021Journal of Clinical Oncology1 citations
Semantic Scholar
Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the U.S. real-world setting.
A. Klink, L. DeMars, Joice Huang, E. Maiese +2 more
20201 citations
Semantic Scholar
Giving voice to patients: Understanding treatment preferences of patients with multiple myeloma (MM).
C. Mckay, E. Maiese, J. Chiarappa, L. Sarokin +4 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Cost per median month of progression-free survival for daratumumab plus bortezomib and dexamethasone compared with carfilzomib plus dexamethasone in relapsed/refractory multiple myeloma
E. Maiese, C. Graham, E. Hawe, J. Le Moine
20181 citations
Semantic Scholar
Comparative efficacy of multiple myeloma therapies for treatment of first relapse: A systematic literature review and network meta-analysis.
E. Maiese, J. Le Moine, C. Ainsworth, Outi Ahdesmäki +1 more
20171 citations
Semantic Scholar
Cost per median overall month of survival in multiple myeloma patients with ≥3 lines of therapy or were double refractory.
E. Maiese, M. Dimova, G. Baio, C. Makin
20161 citations
Semantic Scholar
Characteristics of Multiple Myeloma Patients with Multiple Lines of Therapy Using Real-World US Claims Data
E. Maiese, Brian Macomson, C. Kozma, T. Slaton +1 more
20151 citations Open access
Semantic Scholar
Hospital budget impact of sugammadex (Bridionâ®) for Reversal of Neuromuscular Blockade
R. Insinga, E. Maiese, S. Devine
20151 citations Open access
Semantic Scholar
Effectiveness of Mometasone Furoate Nasal Spray with or without Antibiotics vs. Antibiotic Monotherapy in Patients with Acute Rhinosinusitis in the United Kingdom
E. Maiese, C. de Moor, G. Reardon, J. Mclaughlin +1 more
20111 citations
Semantic Scholar
Correction to: NALIRIFOX Compared With FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma: An Overall Survival External Control Arm Study
D. King, Mei Sheng Duh, Rose Chang, L. Yu +3 more
2026Journal of Clinical Pathways0 citations
Semantic Scholar
Overall survival (OS) with NALIRIFOX (NFX) compared to FOLFIRINOX (FFX) in patients not previously treated for metastatic pancreatic ductal adenocarcinoma (mPDAC): An external control arm study.
M. Duh, Rose Chang, P. Cockrum, L. Yu +3 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Real-world progression-free survival among patients with newly diagnosed advanced ovarian cancer: Does maintenance therapy work?
Ji-Nan Liu, J. Chan, J. Sah, E. Maiese +3 more
2021Journal of Clinical Oncology0 citations
Semantic Scholar
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective
Ji-Nan Liu, C. Hawkes, L. Walder, C. Spalding +3 more
2021Journal of Managed Care & Specialty Pharmacy0 citations Open access
Semantic Scholar
Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
Ji-Nan Liu, P. Thaker, J. Sah, E. Maiese +3 more
2021Journal of Clinical Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Hurteau×6
Invite
J. Hurteau — researcher profile on SciRah
C. Hogea×5
Invite
C. Hogea — researcher profile on SciRah
Ji-Nan Liu×5
Invite
Ji-Nan Liu — researcher profile on SciRah
M. Lafeuille×4
Invite
M. Lafeuille — researcher profile on SciRah

×4

Invite

P. Thaker — researcher profile on SciRah

Invite

S. Usmani — researcher profile on SciRah

Invite

A. Lam — researcher profile on SciRah

Felicia C. Allen-Ramey×3

Invite

Felicia C. Allen-Ramey — researcher profile on SciRah

Invite

J. Le Moine — researcher profile on SciRah

Invite

E. Hawe — researcher profile on SciRah

Invite

Q. Shao — researcher profile on SciRah

C. Deshpande×3

Invite

C. Deshpande — researcher profile on SciRah